AI Medical Billing Startup mutex Raises 281 Million Yen in Series A Funding to Accelerate Automation
Funding Overview
mutex Inc. has raised a total of 281.6 million yen in its Series A funding round. The investors backing this round are MTI Ltd., MEDIPAL Innovation Investment Limited Partnership (the CVC fund of MEDIPAL Holdings Corporation), and Nippon Keiei Co., Ltd. This latest round brings the company's total cumulative funding to 341.6 million yen.
Business and Service Overview
mutex operates in the medical DX sector, providing AI-powered operational support. Its core SaaS product, "Reze," integrates with existing medical billing systems and electronic health records (EHRs), utilizing AI to inspect and assist in correcting missed billing additions and discrepancies in claims. The service aims to reduce the heavy, person-dependent workloads in medical settings and contribute to financial stability for healthcare providers.
Purpose of Funding and Future Outlook
The newly raised capital will be allocated toward expanding paid adoptions of "Reze" among medical institutions and accelerating product development to fully automate medical billing operations. Moving forward, the company plans to expand its platform capabilities from the current pre-billing review process to a comprehensive automated workflow covering everything from medical claim creation and inspection to submission. Additionally, mutex is scheduled to exhibit at the 2nd Medical DX EXPO [Tokyo] in October 2026, where it will showcase live AI-driven demonstrations.
List of Investors
- MTI Ltd.
- MEDIPAL Innovation Investment Limited Partnership (MEDIPAL Holdings Corporation CVC Fund)
- Nippon Keiei Co., Ltd.